Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Ritz

Showing results (271-280 of 334) with videos related to

Pageof 34
Sort By:
Heart (British Cardiac Society)|May 12, 2011
Low homoarginine concentration is a novel risk factor for heart diseaseStefan Pilz, Andreas Meinitzer, Andreas Tomaschitz, et al.
Journal of the American Society of Nephrology : JASN|December 26, 2001
Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal diseaseJan T Kielstein, Rainer H Böger, Stefanie M Bode-Böger, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp RatsMarie-Luise Gross, Marcin Adamczak, Thomas Rabe, et al.
Kidney International|December 11, 2002
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?Martin Zeier, Vedat Schwenger, Reinhold Deppisch, et al.
Nephron. Clinical Practice|November 8, 2014
Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patientsAndreas Schneider, Lena Gutjahr-Lengsfeld, Eberhard Ritz, et al.
American Journal of Physiology. Renal Physiology|January 18, 2008
Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized ratsGrzegorz Piecha, Gabor Kokeny, Kumiko Nakagawa, et al.
Clinical Chemistry|May 5, 2007
B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease StudyKatharina-Susanne Spanaus, Florian Kronenberg, Eberhard Ritz, et al.
Kidney International|August 20, 2010
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce eventsGeorge Bakris, Joseph Vassalotti, Eberhard Ritz, et al.
Clinical Kidney Journal|December 21, 2016
Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY studyJoerg Seckinger, Wilfried Dschietzig, Gerd Leimenstoll, et al.
Plos One|May 22, 2013
Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease StudyChristiane Drechsler, Barbara Kollerits, Andreas Meinitzer, et al.
Pageof 34

Showing results (271-280 of 334) with videos related to

Sort By:
Pageof 34
Heart (British Cardiac Society)|May 12, 2011
Low homoarginine concentration is a novel risk factor for heart diseaseStefan Pilz, Andreas Meinitzer, Andreas Tomaschitz, et al.
Journal of the American Society of Nephrology : JASN|December 26, 2001
Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal diseaseJan T Kielstein, Rainer H Böger, Stefanie M Bode-Böger, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp RatsMarie-Luise Gross, Marcin Adamczak, Thomas Rabe, et al.
Kidney International|December 11, 2002
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?Martin Zeier, Vedat Schwenger, Reinhold Deppisch, et al.
Nephron. Clinical Practice|November 8, 2014
Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patientsAndreas Schneider, Lena Gutjahr-Lengsfeld, Eberhard Ritz, et al.
American Journal of Physiology. Renal Physiology|January 18, 2008
Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized ratsGrzegorz Piecha, Gabor Kokeny, Kumiko Nakagawa, et al.
Clinical Chemistry|May 5, 2007
B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease StudyKatharina-Susanne Spanaus, Florian Kronenberg, Eberhard Ritz, et al.
Kidney International|August 20, 2010
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce eventsGeorge Bakris, Joseph Vassalotti, Eberhard Ritz, et al.
Clinical Kidney Journal|December 21, 2016
Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY studyJoerg Seckinger, Wilfried Dschietzig, Gerd Leimenstoll, et al.
Plos One|May 22, 2013
Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease StudyChristiane Drechsler, Barbara Kollerits, Andreas Meinitzer, et al.
Pageof 34